Rodrigo Puga, Regional President – Middle East, Russia and Africa (MERA), Pfizer
Photo courtesy: Pfizer
In an interview with Zawya Projects, Rodrigo Puga, Regional President for Middle East, Russia and Africa (MERA) at Pfizer Rodrigo Puga, Regional President for Middle East, Russia and Africa (MERA) at Pfizer, outlines the pharma giant’s regional priorities—from AI-driven R&D and supply chain resilience to strategic localisation and public-private partnerships
Eman Hamed
,
ZAWYA Projects
US-based global pharmaceutical and biotechnology giant Pfizer is exploring manufacturing, technology transfer, research and capability-building partnerships across the Middle East and Africa as governments seek greater drug security and access to innovative therapies, according the company’s Regional President for Middle East, Russia and Africa (MERA).
Disclaimer: This article is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Read our full disclaimer policy here.
© ZAWYA 2026